-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Hormone-Related Thrombosis: Duration of Anticoagulation, Risk of Recurrence, and the Role of Hypercoagulability Testing

Program: Education Program
Session: Sex Hormones, Contraceptives, and Thrombotic Risk: Where Are We Now?
Hematology Disease Topics & Pathways:
Bleeding and Clotting, Clinical Practice (Health Services and Quality), Genetic Disorders, Thromboembolism, Diseases, Thrombotic disorders, Treatment Considerations, Maternal Health
Monday, December 9, 2024, 2:45 PM-4:00 PM

Saskia Middeldorp, MD, PhD

Department of Internal Medicine, Radboud university medical center, Nijmegen, Netherlands

Disclosures: Middeldorp: Viatris: Consultancy; Synapse: Research Funding; Sanofi: Consultancy; Norgine: Consultancy; Hemab: Consultancy; Alverong: Consultancy; Astra Zeneca: Consultancy; Bayer: Consultancy; Abbvie: Consultancy.

See more of: Sex Hormones, Contraceptives, and Thrombotic Risk: Where Are We Now?
See more of: Education Program
<< Previous Presentation | Next Presentation